{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Hassannia H"],"funding":["Tehran University of Medical Sciences","National Institute for Medical Research Development"],"pagination":["5827"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9738141"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["14(23)"],"pubmed_abstract":["The receptor tyrosine kinase-like orphan receptor 1 (ROR1) is a new tumor associated antigen (TAA) which is overexpressed in several hematopoietic and solid malignancies. The present study aimed to produce and evaluate different fusion proteins of mouse ROR1 (mROR1) to enhance immunogenicity and protective efficacy of ROR1. Four ROR1 fusion proteins composed of extracellular region of mROR1, immunogenic fragments of TT as well as Fc region of mouse IgG2a were produced and employed to immunize Balb/C mice. Humoral and cellular immune responses and anti-tumor effects of these fusion proteins were evaluated using two different syngeneic murine ROR1+ tumor models. ROR1-specific antibodies were induced in all groups of mice. The levels of IFN-γ, IL-17 and IL-22 cytokines in culture supernatants"],"journal":["Cancers"],"pubmed_title":["Preclinical Assessment of Immunogenicity and Protectivity of Novel ROR1 Fusion Proteins in a Mouse Tumor Model."],"pmcid":["PMC9738141"],"funding_grant_id":["957618"],"pubmed_authors":["Shokri F","Hassannia H","Jeddi-Tehrani M","Sharifian RA","Ghaedi M","Golsaz-Shirazi F","Amiri MM"],"additional_accession":[]},"is_claimable":false,"name":"Preclinical Assessment of Immunogenicity and Protectivity of Novel ROR1 Fusion Proteins in a Mouse Tumor Model.","description":"The receptor tyrosine kinase-like orphan receptor 1 (ROR1) is a new tumor associated antigen (TAA) which is overexpressed in several hematopoietic and solid malignancies. The present study aimed to produce and evaluate different fusion proteins of mouse ROR1 (mROR1) to enhance immunogenicity and protective efficacy of ROR1. Four ROR1 fusion proteins composed of extracellular region of mROR1, immunogenic fragments of TT as well as Fc region of mouse IgG2a were produced and employed to immunize Balb/C mice. Humoral and cellular immune responses and anti-tumor effects of these fusion proteins were evaluated using two different syngeneic murine ROR1+ tumor models. ROR1-specific antibodies were induced in all groups of mice. The levels of IFN-γ, IL-17 and IL-22 cytokines in culture supernatants","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Nov","modification":"2025-04-04T08:00:43.285Z","creation":"2024-11-12T18:43:02.039Z"},"accession":"S-EPMC9738141","cross_references":{"pubmed":["36497309"],"doi":["10.3390/cancers14235827"]}}